Drawtex Hydroconductive Wound Dressing

Drawtex®, the first product in our new wound care range, offers an intelligent advance in wound bed preparation. Drawtex® is a novel hydroconductive wound dressing based on patented LevaFiber™ technology, which applies the latest thinking in materials technology and offers a new perspective in handling exudate and reducing slough and necrotic tissue. It has a capacity to:

• Reduce excess exudate1
• Remove biofilm nutrients2
• Reduce inflammation2
• Loosen slough2
• Reduce bacterial bioburden2
• Decrease deleterious cytokines in the wound bed3

The LevaFiber™ technology combines absorbent, cross-action structures that enable the dressing to draw large volumes of exudate and other debris from the wound and through the dressing. This hydroconductive debridement allows Drawtex® to lift, hold and transfer exudate both vertically and horizontally into the body of the dressing, where it can absorb five times its own weight.

Clinically, results have shown that Drawtex® can decrease wound exudate, tissue bacterial levels, nutrients for biofilm production and deleterious cytokine levels such as matrix metalloproteinases (MMP-1 and MMP-9)1, 4, 5. Based on these actions, Drawtex® facilitates effective wound bed preparation and kick-starts healing, which makes it a possible alternative to passive absorptive products, like calcium alginates, hydrofibers, foams and superabsorbers6. On occasions, it has also been seen to be able to replace some enzymatic, antimicrobial and negative-pressure wound therapy (NPWT)7.

It also offers benefits both to healthcare professionals and patients in that it can be cut and tailored to any anatomical location, layered to manage heavily exuding wounds, and will not shed fibres or fall apart, even when soaked.

For more details about this innovative product, contact us by phone on 0800 028 7933, email at connect@martindalepharma.co.uk or use the form below.

Name*

Email*

Phone Number

Message

For security, copy the text from the image below